$2.73
Today
as of Oct 2, 16:46 ET
Last 30 days
Recent Press Releases & News
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
BSEM earnings at a glance
BSEM beat the consensus EPS estimate in 0 of its last 1 reported quarters. The share price of $2.73 sits near its 52-week low.
Overview
52-week range
$2.25
$8.40
8% of range
Avg surprise (last 1)
-113.6%
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.52 | — | — | — | — | financials |
| Thu Nov 13, 2025 | Sep/2025 | $0.03 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.03 | $0.22 | -113.6% | — | — | earnings |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | $8M | — | $11M |
| Cost of revenue | $3M | — | $685,177 |
| Gross profit | $5M | — | $10M |
| Operating income | $-8M | — | $112,759 |
| Net income | $-9M | — | $10,613 |
| EPS (diluted) | $-0.52 | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|
| Cash & equivalents | $7M | $30M | — |
| Inventory | $5M | $3M | — |
| Total current assets | $21M | $44M | — |
| Total assets | $49M | $50M | — |
| Long-term debt | $0 | $0 | — |
| Total liabilities | $21M | $11M | — |
| Total equity | $28M | $39M | $47M |
Implied volatility — last 90 days
No IV snapshots yet for BSEM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.